Figure 1From: Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inferenceChanges in regional BMD. Changes in regional BMD in the spine, femoral neck, trochanter, and Ward's triangle in patients receiving T4-suppressive therapy treated with intranasal calcitonin plus calcium (▲), calcium alone (●), or placebo (○). Values are the mean ± SD. P < 0.05 vs. baseline reading. (With permission of Kung AW, Yeung SS. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin. J Clin Endocrinol Metab 1996; 81:1232-6)Back to article page